These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 20004150
1. Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients. Schelstraete P, Deschaght P, Van Simaey L, Van Daele S, Haerynck F, Vaneechoutte M, De Baets F. J Cyst Fibros; 2010 Mar; 9(2):99-103. PubMed ID: 20004150 [Abstract] [Full Text] [Related]
2. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. Hansen CR, Pressler T, Høiby N. J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078 [Abstract] [Full Text] [Related]
3. Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism. Ho SA, Lee TW, Denton M, Conway SP, Brownlee KG. J Cyst Fibros; 2009 Jan; 8(1):43-6. PubMed ID: 18829398 [Abstract] [Full Text] [Related]
4. [Bacteriological monitoring of the treatment of Pseudomonas aeruginosa infections with amikacin administrated at once-daily dosis in patients with cystic fibrosis]. Canis F, Husson MO, Vic P, Ategbo S, Turck D, Courcol R, Leclerc H. Pathol Biol (Paris); 1995 Apr; 43(4):343-51. PubMed ID: 7567127 [Abstract] [Full Text] [Related]
5. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Ratjen F, Walter H, Haug M, Meisner C, Grasemann H, Döring G. Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185 [Abstract] [Full Text] [Related]
6. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients. Hansen CR, Pressler T, Hoiby N, Johansen HK. J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202 [Abstract] [Full Text] [Related]
7. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India. Agarwal G, Kapil A, Kabra SK, Chandra R, Das B, Diwedi SN. Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994 [Abstract] [Full Text] [Related]
8. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Taccetti G, Campana S, Festini F, Mascherini M, Döring G. Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728 [Abstract] [Full Text] [Related]
9. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Ratjen F, Munck A, Kho P, Angyalosi G, ELITE Study Group. Thorax; 2010 Apr; 65(4):286-91. PubMed ID: 19996339 [Abstract] [Full Text] [Related]
10. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. Pressler T, Karpati F, Granström M, Knudsen PK, Lindblad A, Hjelte L, Olesen HV, Meyer P, Høiby N, Scandinavian CF Study Consortium. J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753 [Abstract] [Full Text] [Related]
11. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. J Infect Dis; 2001 Feb 01; 183(3):444-52. PubMed ID: 11133376 [Abstract] [Full Text] [Related]
12. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients. Nazik H, Ongen B, Erturan Z, Salcioğlu M. Jpn J Infect Dis; 2007 May 01; 60(2-3):82-6. PubMed ID: 17515637 [Abstract] [Full Text] [Related]
13. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis. Ferroni A, Guillemot D, Moumile K, Bernede C, Le Bourgeois M, Waernessyckle S, Descamps P, Sermet-Gaudelus I, Lenoir G, Berche P, Taddei F. Pediatr Pulmonol; 2009 Aug 01; 44(8):820-5. PubMed ID: 19598278 [Abstract] [Full Text] [Related]
14. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility. Mereghetti L, Marquet-van der Mee N, Loulergue J, Rolland JC, Audurier A. Pathol Biol (Paris); 1998 May 01; 46(5):319-24. PubMed ID: 9769892 [Abstract] [Full Text] [Related]
15. Familial concordance of phenotype and microbial variation among siblings with CF. Picard E, Aviram M, Yahav Y, Rivlin J, Blau H, Bentur L, Avital A, Villa Y, Schwartz S, Kerem B, Kerem E. Pediatr Pulmonol; 2004 Oct 01; 38(4):292-7. PubMed ID: 15334505 [Abstract] [Full Text] [Related]
16. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study. Hansen CR, Pressler T, Koch C, Høiby N. J Cyst Fibros; 2005 Mar 01; 4(1):35-40. PubMed ID: 15752679 [Abstract] [Full Text] [Related]
17. Evaluation of the efficacy of real-time polymerase chain reaction for the routine early detection of Pseudomonas aeruginosa in cystic fibrosis sputum and throat swab specimens. Logan C, Habington A, Lennon G, Cronin F, O'Sullivan N. Diagn Microbiol Infect Dis; 2010 Dec 01; 68(4):358-65. PubMed ID: 20884156 [Abstract] [Full Text] [Related]
18. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A, Scandinavian CF Study Consortium (SCFSC). J Cyst Fibros; 2009 Mar 01; 8(2):135-42. PubMed ID: 19157995 [Abstract] [Full Text] [Related]
19. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. da Silva Filho LV, Tateno AF, Martins KM, Azzuz Chernishev AC, Garcia Dde O, Haug M, Meisner C, Rodrigues JC, Döring G. Pediatr Pulmonol; 2007 Oct 01; 42(10):938-44. PubMed ID: 17722007 [Abstract] [Full Text] [Related]